BriaCell advances melanoma vaccine candidate to genetic engineering milestone

Go back to BriaCell advances melanoma vaccine candidate to genetic engineering milestone
(NASDAQ: BCTX) Delayed: 4.15 -0.06 (1.43%)
Previous Close $4.21    52 Week High
Open $4.16    52 Week Low
Day High $4.22    P/E N/A 
Day Low $4.03    EPS
Volume 167,675